Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sensus Healthcare (SRTS) Interest & Investment Income (2016 - 2024)

Sensus Healthcare (SRTS) has 8 years of Interest & Investment Income data on record, last reported at $279000.0 in Q3 2024.

  • For Q3 2024, Interest & Investment Income rose 0.72% year-over-year to $279000.0; the TTM value through Sep 2024 reached $979000.0, down 2.1%, while the annual FY2022 figure was $382000.0, 19000.0% up from the prior year.
  • Interest & Investment Income reached $279000.0 in Q3 2024 per SRTS's latest filing, up from $209000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $279000.0 in Q3 2024 and bottomed at $1000.0 in Q4 2021.
  • Average Interest & Investment Income over 5 years is $136837.0, with a median of $165000.0 recorded in 2022.
  • Peak YoY movement for Interest & Investment Income: plummeted 97.7% in 2020, then soared 24200.0% in 2023.
  • A 5-year view of Interest & Investment Income shows it stood at $1718.0 in 2020, then crashed by 41.79% to $1000.0 in 2021, then surged by 23400.0% to $235000.0 in 2022, then increased by 17.87% to $277000.0 in 2023, then grew by 0.72% to $279000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $279000.0 in Q3 2024, $209000.0 in Q2 2024, and $214000.0 in Q1 2024.